XOOMAR
Get a free API key

Anavex Life Sciences (AVXL)

Anavex Life Sciences on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

12.5M

Short interest

settlement 2026-10-15

8.1

Days to cover

-5.5 days vs prior

58.9%

Short share of volume

2026-11-02

1

Fails to deliver

settlement 2026-10-14

Tue 24 Nov

Next earnings

estimated date

$0

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in AVXL is 12,548,190 shares, down 1,785,188 shares over the last month. Over the last 48 readings it ranged from 12,548,190 shares (15 October 2026) to 28,742,805 shares (14 November 2025). The latest reading sits at the bottom of that range. At the reported average volume of 1.6M shares a day that is 8.1 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/avxl" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-1512,548,190-7.5%1,554,9508.07
2026-09-3013,566,524-5.3%1,000,75713.56
2026-09-1514,333,378+3.1%570,26025.13
2026-08-3113,898,140-1.5%834,18416.66
2026-08-1414,106,490-2.2%985,60114.31
2026-07-3114,426,670+2.0%999,85514.43
2026-07-1514,140,060-0.6%906,50815.60
2026-06-3014,228,756-18.8%2,072,0616.87
2026-06-1517,526,141-7.0%1,150,85915.23
2026-05-2918,834,525-2.1%1,132,38416.63
2026-05-1519,232,245+1.2%980,25119.62
2026-04-3019,011,626+0.3%835,31822.76
2026-04-1518,950,432-1.6%1,103,57217.17
2026-03-3119,262,453-9.2%2,772,6666.95
2026-03-1321,206,863+4.1%996,91921.27
2026-02-2720,366,318-0.8%943,66121.58
2026-02-1320,532,909+2.9%1,559,19813.17
2026-01-3019,953,236+0.8%1,232,12516.19
2026-01-1519,787,447+0.7%1,611,45812.28
2025-12-3119,650,578-14.7%2,454,2728.01
2025-12-1523,042,899-8.3%2,536,4829.08
2025-11-2825,139,901-12.5%3,725,9966.75
2025-11-1428,742,805+7.8%4,584,5746.27
2025-10-3126,664,141+0.2%1,008,04026.45
2025-10-1526,617,983+6.0%1,713,24215.54
2025-09-3025,107,307+1.1%960,84626.13
2025-09-1524,840,667-2.6%1,177,41521.10
2025-08-2925,510,330+0.6%792,48232.19
2025-08-1525,368,322+2.3%950,87726.68
2025-07-3124,810,859-1.3%1,341,66118.49
2025-07-1525,145,706+0.1%993,74025.30
2025-06-3025,122,132-0.4%1,140,32322.03
2025-06-1325,212,383+0.7%718,36935.10
2025-05-3025,029,355+3.9%1,037,98424.11
2025-05-1524,099,499+2.6%833,31528.92
2025-04-3023,491,437-2.2%558,95342.03
2025-04-1524,012,729-2.3%1,335,62717.98
2025-03-3124,588,383+2.3%1,186,83620.72
2025-03-1424,042,495+2.5%954,18925.20
2025-02-2823,444,371-3.1%1,056,06222.20
2025-02-1424,204,459+3.3%1,043,01823.21
2025-01-3123,425,067+0.1%1,346,75617.39
2025-01-1523,395,280+7.3%2,387,7889.80
2024-12-3121,800,438+4.7%2,978,5007.32
2024-12-1320,821,516+5.7%1,269,74716.40
2024-11-2919,693,094+4.7%1,583,94812.43
2024-11-1518,810,768+2.7%1,869,92110.06
2024-10-3118,308,959+2.3%988,48618.52

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of AVXL volume is 58.9%, up 1.5 points over the last five sessions. Over the last 30 readings it ranged from 34.1% (27 October 2026) to 79.5% (29 September 2026). The latest reading is in line with the 30-session average of 58.0%, on 473K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-02279K473K58.9%0
2026-10-30302K530K57.1%0
2026-10-29213K453K47.0%0
2026-10-28174K405K43.1%54
2026-10-27195K571K34.1%52
2026-10-26262K457K57.4%2,400
2026-10-23165K275K60.2%2,300
2026-10-22198K429K46.2%1,138
2026-10-21383K510K75.1%0
2026-10-20590K891K66.2%62,563
2026-10-19487K1.0M48.6%29,565
2026-10-16566K847K66.9%33,525
2026-10-15456K590K77.2%22
2026-10-14381K573K66.4%1
2026-10-13402K627K64.0%0
2026-10-12278K433K64.2%0
2026-10-09444K681K65.2%0
2026-10-08203K385K52.7%1,708
2026-10-07311K581K53.6%0
2026-10-06460K765K60.1%30,087
2026-10-05474K959K49.4%12,675
2026-10-02542K1.1M48.2%10,849
2026-10-01579K1.3M45.0%157,399
2026-09-30698K1.4M48.3%136,283
2026-09-29633K797K79.5%2,907
2026-09-2882K184K44.3%0
2026-09-25237K312K75.9%0
2026-09-24262K459K57.0%107
2026-09-23332K430K77.1%5,482
2026-09-22116K233K49.7%1,034

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 14 October 2026, the fails-to-deliver balance in AVXL is 1 share, down 20,137 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (14 October 2026) to 2,556,441 shares (22 June 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-10-141$1.48$1
2026-10-1320,138$1.51$30K
2026-10-0921,139$1.54$33K
2026-10-083,356$1.53$5K
2026-10-0212,340$1.89$23K
2026-09-2429,909$2.35$70K
2026-09-231,844$2.47$5K
2026-09-2238,689$2.40$93K
2026-09-2169$2.42$167
2026-09-1016$2.75$44
2026-09-09155$2.85$442
2026-09-023,582$2.87$10K
2026-08-311,494$2.99$4K
2026-08-252,628$3.11$8K
2026-08-2026$3.39$88
2026-08-0459$2.95$174
2026-08-0332$2.75$88
2026-07-24510$2.48$1K
2026-07-1795$2.34$222
2026-07-13427$2.50$1K
2026-07-103,000$2.70$8K
2026-07-0216,604$2.58$43K
2026-06-3078,389$2.60$204K
2026-06-2951,983$2.62$136K
2026-06-2515,941$2.56$41K
2026-06-232,377,571$2.54$6.0M
2026-06-222,556,441$2.73$7.0M
2026-06-152,383$2.50$6K
2026-06-1239,354$2.50$98K
2026-06-0336,294$2.79$101K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for AVXL in the last 90 days. The most recent filings are listed below. Latest filing: MISSLING CHRISTOPHER U (President and CEO) on 2025-09-11.

DateInsiderTitleTypeSharesPriceValueOwned after
2025-09-11MISSLING CHRISTOPHER UPresident and CEOTax withholding145K$9.58$1.4M1.5M
2025-09-11MISSLING CHRISTOPHER UPresident and CEOExercise or conversion188K$5.04$945K1.7M
2025-06-05Thomas SteffenDirectorExercise or conversion50K$1.76$88K55K
2025-06-05Thomas SteffenDirectorTax withholding11K$7.75$88K44K
2025-03-24MISSLING CHRISTOPHER UPresident and CEOExercise or conversion500K$0.92$460K1.8M
2025-03-24MISSLING CHRISTOPHER UPresident and CEOTax withholding282K$9.63$2.7M1.5M
2024-06-14Donhauser Peter D.O.DirectorBuy3K$3.64$10K5K
2024-05-15Thomas SteffenDirectorBuy5K$4.52$23K5K
2024-03-28MISSLING CHRISTOPHER UPresident and CEOExercise or conversion73K$1.32$97K1.3M
2024-03-28MISSLING CHRISTOPHER UPresident and CEOSell73K$5.11$375K1.3M
2023-06-29MISSLING CHRISTOPHER UPresident and CEOExercise or conversion232K$1.60$371K1.3M
2023-06-28MISSLING CHRISTOPHER UPresident and CEOExercise or conversion268K$1.60$429K1.3M
2023-06-28MISSLING CHRISTOPHER UPresident and CEOSell268K$7.98$2.1M1.0M
2022-05-25Skarpelos AthanasiosDirectorSell50K$9.06$453K1.3M
2022-05-25Skarpelos AthanasiosDirectorExercise or conversion50K$0.92$46K1.4M
2021-06-29Boenisch SandraPFO and TreasurerExercise or conversion25K$5.68$142K48K
2021-06-29Boenisch SandraPFO and TreasurerExercise or conversion107K$3.28$350K155K
2021-06-29Boenisch SandraPFO and TreasurerExercise or conversion35K$5.92$207K190K
2021-06-29Boenisch SandraPFO and TreasurerSell167K$26.53$4.4M23K
2021-06-29MISSLING CHRISTOPHER UPresident and CEOExercise or conversion52K$1.32$68K1.1M
2021-06-29MISSLING CHRISTOPHER UPresident and CEOSell52K$26.00$1.3M1.0M
2021-05-21FAVUS ELLIOTDirectorExercise or conversion50K$2.96$148K145K
2021-05-21FAVUS ELLIOTDirectorExercise or conversion2K$6.11$9K95K
2021-05-21FAVUS ELLIOTDirectorExercise or conversion2K$5.66$8K94K
2021-05-21FAVUS ELLIOTDirectorExercise or conversion2K$4.90$7K92K
2021-05-21FAVUS ELLIOTDirectorExercise or conversion2K$5.57$8K91K
2021-05-21FAVUS ELLIOTDirectorSell145K$11.70$1.7M0
2021-05-21FAVUS ELLIOTDirectorExercise or conversion2K$5.64$8K89K
2021-05-21FAVUS ELLIOTDirectorExercise or conversion50K$0.92$46K88K
2021-05-21FAVUS ELLIOTDirectorExercise or conversion38K$1.20$45K38K
2021-05-17Donhauser Peter D.O.DirectorBuy1K$10.93$11K2K
2021-02-24FAVUS ELLIOTDirectorExercise or conversion46K$2.58$117K45K
2021-02-24FAVUS ELLIOTDirectorExercise or conversion100K$3.28$328K145K
2021-02-24FAVUS ELLIOTDirectorSell146K$12.66$1.8M0
2021-02-19Donhauser Peter D.O.DirectorBuy165$12.97$2K1K
2021-02-19Donhauser Peter D.O.DirectorBuy1K$12.62$13K1K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

1 holder reports 5% or more of AVXL in its latest filing, on Schedule 13G (passive). The holder is Vanguard Capital Management at 5.0% of the class (4,663,459 shares), filed 2026-07-31 for an event on 2026-06-30.

FiledFormHolderSharesOf classEvent
2026-07-3113GVanguard Capital Managementinvestment adviser4.7M5.0%2026-06-30
2026-03-2613G/Ano. 3The Vanguard Groupinvestment adviser00.0%2026-03-13

13F holders

Tracked managers holding AVXL at their latest 13F. JSON

6 of the 30 tracked managers held AVXL at their latest 13F, $12.1M in total at quarter-end prices. Two Sigma Investments is the largest at $7.9M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 2 cut.

FundQuarterSharesValueOf portfolioChange in shares
Two Sigma Investments2026-06-303.0M$7.9M0.01%-201K
AQR Capital Management2026-06-30963K$2.5M0.00%+206K
Citadel Advisors2026-06-30329K$852K0.00%-230K
Point72 Asset Management2026-06-30157K$408K0.00%new
D. E. Shaw & Co.2026-06-30115K$299K0.00%+71K
Millennium Management2026-06-3060K$157K0.00%new

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Anavex Life Sciences in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Anavex Life Sciences (AVXL), SEC CIK 1314052, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-07-31.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-30.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2025-09-11.JSON and CSV
Company record
EDGAR filing index for CIK 1314052Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other company pages

Datasets

Frequently Asked Questions

How much of AVXL is sold short?
12,548,190 shares were held short at the 2026-10-15 settlement, 8.1 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is AVXL's daily short volume?
On 2026-11-02, 278,714 of the 473,412 AVXL shares reported to FINRA were sold short, 58.9% of the day's reported volume. Short volume is a flow for one day, not a position.
Does AVXL have fails to deliver?
The SEC's latest file shows 1 AVXL shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.
Are AVXL insiders buying or selling?
No open-market insider trades were reported for AVXL in the last 90 days. The most recent filings are listed below. Latest filing: MISSLING CHRISTOPHER U (President and CEO) on 2025-09-11.
Who owns 5% or more of AVXL?
1 holder reports 5% or more of AVXL in its latest filing, on Schedule 13G (passive). The holder is Vanguard Capital Management at 5.0% of the class (4,663,459 shares), filed 2026-07-31 for an event on 2026-06-30.
Which tracked 13F managers own AVXL?
6 of the 30 tracked 13F managers held AVXL shares at their latest filing, $12.1M in all. The largest: Two Sigma Investments (3.0M shares, $7.9M), Cliff Asness's AQR Capital Management (963K shares, $2.5M), Ken Griffin's Citadel Advisors (329K shares, $852K), Steve Cohen's Point72 Asset Management (157K shares, $408K), D. E. Shaw & Co. (115K shares, $299K), Izzy Englander's Millennium Management (60K shares, $157K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.